Also, OBs derived from primary MSCs resulted more sensitive to higher dasatinib doses than OBs derived from the hMSC-TERT cell line (Figure 2B, left graph vs right graph), with no significant differences in the number of viable OBs derived from MM patients and healthy donors (data not shown). Here, TERT is linked to Miyoshi myopathy.